Literature DB >> 11027671

Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells.

R M Korah1, V Sysounthone, E Scheff, R Wieder.   

Abstract

To test the implicated role of basic fibroblast growth factor (bFGF; FGF-2) in promoting differentiation in breast cancer, we enforced the expression of FGF-2 in T-47D breast cancer cells. Expression of FGF-2 conferred an overall less malignant phenotype to T-47D cells as revealed by their reduced proliferative response, impaired capacity for anchorage-independent growth, and invasion through Matrigel. To understand one candidate mechanism for the intracellular FGF-2-mediated anti-invasive effect, we examined the effect of FGF-2 on T-47D cell motility. Addition of recombinant FGF-2 to the growth medium markedly enhanced cell motility while constitutive expression of intracellular FGF-2 significantly inhibited the migratory potential of T-47D cells in a dominant manner. FGF-2-expressing T-47D cells also formed relatively defined branching structures in Matrigel matrices, a characteristic phenotype of differentiation in breast cancer cells. These data suggest a potential role for FGF-2 in promoting functional differentiation of breast epithelial cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027671     DOI: 10.1006/bbrc.2000.3655

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation.

Authors:  Samir Tivari; Reju Korah; Michael Lindy; Robert Wieder
Journal:  J Vis Exp       Date:  2015-06-30       Impact factor: 1.355

Review 2.  A new hypothesis for the cancer mechanism.

Authors:  Xiaolong Meng; Jie Zhong; Shuying Liu; Mollianne Murray; Ana M Gonzalez-Angulo
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Authors:  Xiaohui Bi; Meera Hameed; Neena Mirani; Erica Maria Pimenta; Jason Anari; Betsy J Barnes
Journal:  Breast Cancer Res       Date:  2011-11-04       Impact factor: 6.466

4.  Use of three-dimensional collagen gels to study mechanotransduction in T47D breast epithelial cells.

Authors:  Michele A Wozniak; Patricia J Keely
Journal:  Biol Proced Online       Date:  2005-10-17       Impact factor: 3.244

5.  Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.

Authors:  Judith Barrios; Robert Wieder
Journal:  Cancer Microenviron       Date:  2009-03-18

6.  FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression.

Authors:  Louise Firme; Andrew B Bush
Journal:  BMC Cell Biol       Date:  2003-12-04       Impact factor: 4.241

7.  Ligand-dependent corepressor contributes to transcriptional repression by C2H2 zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1.

Authors:  Mario R Calderon; Mark Verway; Radia Ouelaa Benslama; Mirela Birlea; Manuella Bouttier; Vassil Dimitrov; Sylvie Mader; John H White
Journal:  Nucleic Acids Res       Date:  2014-05-14       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.